IFNA1 and infection: While all HIE lines showed some increase in VA1 genome copies with ruxolitinib treatment, pharmacologic inhibition of IFN signaling had the greatest effect on VA1 infection in C143 HIE, which could not be infected in the absence of the inhibitor.